Discovered on gastrointestinal stromal tumour 1 (DOG1): A useful immunohistochemical marker for diagnosing chondroblastoma

Histopathology

Volumn 60, Issue 7, 2012, Pages 1099-1106

  Akpalo, Hana ^a   Lange, Claudia ^a   Zustin, Jozef ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bone tumours; Cartilage; Chondroblastoma; Discovered on GIST1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD163 ANTIGEN; CYTOKERATIN AE1; CYTOKERATIN AE3; DISCOVERED ON GASTROINTESTINAL STROMAL TUMOR 1 PROTEIN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CARTILAGE CELL; CELL INFILTRATION; CHILD; CHONDROBLASTOMA; CHONDROMYXOID FIBROMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FEMUR; FETUS; FIBROMA; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; OSTEOCLAST; OSTEOCLASTOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR DIAGNOSIS;

ACTINS; ADOLESCENT; ADULT; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANTIPORTERS; BONE NEOPLASMS; CHILD; CHLORIDE CHANNELS; CHONDROBLASTOMA; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84861483800     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04152.x     Document Type: Article

References (64)

1. Fletcher Christopher DM. UKK, Mertens Frederik ed. WHO classification of tumours. Lyon: IARC Press, 2002.
2. Hudson TM, Hawkins IF Jr. Radiological evaluation of chondroblastoma. Radiology 1981; 139; 1-10.
3. Rahimi A, Beabout JW, Ivins JC, Dahlin DC. Chondromyxoid fibroma: a clinicopathologic study of 76 cases. Cancer 1972; 30; 726-736.
4. Huang L, Cheng YY, Chow LT, Zheng MH, Kumta SM. Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment. Mol. Pathol. 2003; 56; 116-120.
5. Codman EA. The classic: epiphyseal chondromatous giant cell tumors of the upper end of the humerus. Surg. Gynecol. Obstet. 1931; 52; 543. Clin. Orthop. Relat. Res. 2006; 450: 12-16.
6. Jaffe HL, Lichtenstein L. Benign chondroblastoma of bone: a reinterpretation of the so-called calcifying or chondromatous giant cell tumor. Am. J. Pathol. 1942; 18; 969-991.
7. Povysil C. Actin-positive chondroblasts (myochondroblasts) in benign chondroblastoma. Cesk. Patol. 1995; 31; 77-78.
8. Povysil C, Matejovsky Z. Ultrastructure of benign chondroblastoma. Pathol. Res. Pract. 1979; 166; 80-89.
9. Povysil C, Matejovsky Z, Runt M. [Benign chondroblastoma]. Cesk. Patol. 1981; 17; 77-82.
10. Povysil C, Tomanova R, Matejovsky Z. Muscle-specific actin expression in chondroblastomas. Hum. Pathol. 1997; 28; 316-320.
11. Bousdras K, O'Donnell P, Vujovic S, Henderson S, Boshoff C, Flanagan AM. Chondroblastomas but not chondromyxoid fibromas express cytokeratins: an unusual presentation of a chondroblastoma in the metaphyseal cortex of the tibia. Histopathology 2007; 51; 414-416.
12. Ho YH, Cheng MH, Yap WM, Chuah KL. Cytokeratin-, calponin-, and p63-positive chondroblastoma with extensive soft tissue involvement and vascular invasion: a potential diagnostic dilemma. Ann. Diagn. Pathol. 2011; 15; 58-63.
13. Hong SM, Park YK, Ro JY. Chondroblastoma of the temporal bone: a clinicopathologic study of five cases. J. Korean Med. Sci. 1999; 14; 559-564.
14. Edel G, Ueda Y, Nakanishi J et al. Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study. Virchows Arch. A Pathol. Anat. Histopathol. 1992; 421; 355-366.
15. Semmelink HJ, Pruszczynski M, Wiersma-van Tilburg A, Smedts F, Ramaekers FC. Cytokeratin expression in chondroblastomas. Histopathology 1990; 16; 257-263.
16. Zustin J, Akpalo H, Gambarotti M et al. Phenotypic diversity in chondromyxoid fibroma reveals differentiation pattern of tumor mimicking fetal cartilage canals development: an immunohistochemical study. Am. J. Pathol. 2010; 177; 1072-1078.
17. Brien EW, Mirra JM, Ippolito V. Chondroblastoma arising from a nonepiphyseal site. Skeletal Radiol. 1995; 24; 220-222.
18. Bliss DG, Mann RJ. Chondroblastoma of a metacarpal. Report of a case and review of the literature. Clin. Orthop. Relat. Res. 1985; 194; 211-213.
19. Romeo S, Bovee JV, Jadnanansing NA, Taminiau AH, Hogendoorn PC. Expression of cartilage growth plate signalling molecules in chondroblastoma. J. Pathol. 2004; 202; 113-120.
20. Bloem JL, Mulder JD. Chondroblastoma: a clinical and radiological study of 104 cases. Skeletal Radiol. 1985; 14; 1-9.
21. McLeod RA, Beabout JW. The roentgenographic features of chondroblastoma. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1973; 118; 464-471.
22. Konishi E, Nakashima Y, Iwasa Y, Nakao R, Yanagisawa A. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum. Pathol. 2010; 41; 208-213.
23. Mii Y, Miyauchi Y, Morishita T et al. Ultrastructural cytochemical demonstration of proteoglycans and calcium in the extracellular matrix of chondroblastomas. Hum. Pathol. 1994; 25; 1290-1294.
24. Aigner T, Loos S, Inwards C et al. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J. Pathol. 1999; 189; 463-469.
25. Clapper AT, DeYoung BR. Chondroblastoma of the femoral diaphysis: report of a rare phenomenon and review of literature. Hum. Pathol. 2007; 38; 803-806.
26. Park HR, Park YK, Jang KT, Unni KK. Expression of collagen type II, S100B, S100A2 and osteocalcin in chondroblastoma and chondromyxoid fibroma. Oncol. Rep. 2002; 9; 1087-1091.
27. Soder S, Oliveira AM, Inwards CY, Muller S, Aigner T. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma. Pathology 2006; 38; 35-38.
28. Schorle CM, Inwards C, Unni KK, Kirchner T, Aigner T. [Characterisation and differentiation of chondroblastomas and chondromyxoidfibromas - presence and expression of collagen types I and II]. Z. Orthop. Ihre Grenzgeb. 2002; 140; 208-213.
29. Serra M, Morini MC, Scotlandi K et al. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors. Hum. Pathol. 1992; 23; 1326-1331.
30. Jundt G, Schulz A, Berghauser KH, Fisher LW, Gehron-Robey P, Termine JD. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies. Virchows Arch. A Pathol. Anat. Histopathol. 1989; 414; 345-353.
31. Daugaard S, Christensen LH, Hogdall E. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40. Acta Pathol. Microbiol. Immunol. 2009; 117; 518-525.
32. Takeda Y. An immunohistochemical study of bizarre neoplastic cells in pleomorphic adenoma: its cytological nature and proliferative activity. Pathol. Int. 1999; 49; 993-999.
33. West RB, Corless CL, Chen X et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am. J. Pathol. 2004; 165; 107-113.
34. Espinosa I, Lee CH, Kim MK et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am. J. Surg. Pathol. 2008; 32; 210-218.
35. Wong NA, Shelley-Fraser G. Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour. Histopathology 2010; 57; 250-258.
36. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am. J. Surg. Pathol. 2009; 33; 1401-1408.
37. Gomez-Pinilla PJ, Gibbons SJ, Bardsley MR et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am. J. Physiol. Gastrointest. Liver Physiol. 2009; 296; G1370-G1381.
38. Tian Y, Kongsuphol P, Hug M et al. Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A. FASEB J. 2011; 25; 1058-1068.
39. Caputo A, Caci E, Ferrera L et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008; 322; 590-594.
40. Schroeder BC, Cheng T, Jan YN, Jan LY. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 2008; 134; 1019-1029.
41. Yang YD, Cho H, Koo JY et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 2008; 455; 1210-1215.
42. Hartzell C, Putzier I, Arreola J. Calcium-activated chloride channels. Annu. Rev. Physiol. 2005; 67; 719-758.
43. Ousingsawat J, Martins JR, Schreiber R, Rock JR, Harfe BD, Kunzelmann K. Loss of TMEM16A causes a defect in epithelial Ca2+-dependent chloride transport. J. Biol. Chem. 2009; 284; 28698-28703.
44. - secretory channel in mouse airways. J. Biol. Chem. 2009; 284; 14875-14880.
45. - channel in mouse submandibular salivary gland acinar cells. J. Biol. Chem. 2010; 285; 12990-13001.
46. Huang F, Rock JR, Harfe BD et al. Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc. Natl Acad. Sci. USA 2009; 106; 21413-21418.
47. Hwang SJ, Blair PJ, Britton FC et al. Expression of anoctamin 1/TMEM16A by interstitial cells of Cajal is fundamental for slow wave activity in gastrointestinal muscles. J. Physiol. 2009; 587; 4887-4904.
48. - channels. J. Clin. Invest. 2010; 120; 1240-1252.
49. Li Y, Kojima H, Fujino K et al. Homing of the bone marrow-derived interstitial cells of Cajal is decreased in diabetic mouse intestine. J. Gastroenterol. Hepatol. 2011; 26; 1072-1078.
50. Liu D, Wang F, Zou Z et al. Bone marrow derivation of interstitial cells of Cajal in small intestine following intestinal injury. J. Biomed. Biotechnol. 2010; 2010; 164986.
51. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284; 143-147.
52. Nakajima T, Miwa S, Ando T et al. [Three cases of gastrointestinal stromal tumor (GIST) with bone metastasis]. Nippon Shokakibyo Gakkai Zasshi 2008; 105; 836-840.
53. Tezcan Y, Koc M. Gastrointestinal stromal tumor of the rectum with bone and liver metastasis: a case study. Med. Oncol. 2010; 28; 204-206.
54. Ishikawa A, Teratani T, Ono S et al. [A case of gastrointestinal stromal tumor with liver and bone metastases effectively treated with radiofrequency ablation and imatinib mesylate]. Nippon Shokakibyo Gakkai Zasshi 2006; 103; 1274-1279.
55. Tomic S, Lesic A, Bumbasirevic M, Sopta J, Rakocevic Z, Atkinson HD. An aggressive chondroblastoma of the knee treated with resection arthrodesis and limb lengthening using the Ilizarov technique. J. Orthop. Surg. Res. 2010; 5; 47.
56. Mohamed B, Madiha M, Ridha S et al. [Aggressive spinal chondroblastoma]. Tunis. Med. 2010; 88; 134-136.
57. Bandyopadhyay A, Chakraborty J, Choudhuri MK et al. Recurrent and aggressive chondroblastoma: a case report. Indian J. Pathol. Microbiol. 2007; 50; 780-782.
58. Kirchhoff C, Buhmann S, Mussack T et al. Aggressive scapular chondroblastoma with secondary metastasis-a case report and review of literature. Eur. J. Med. Res. 2006; 11; 128-134.
59. Harish K, Janaki MG, Alva NK. 'Primary' aggressive chondroblastoma of the humerus: a case report. BMC Musculoskelet. Disord. 2004; 5; 9.
60. Schajowicz F, De Prospero JD, Cosentino E. Case report 641: chondroblastoma-like osteosarcoma. Skeletal Radiol. 1990; 19; 603-606.
61. Bacchini P, Inwards C, Biscaglia R, Picci P, Bertoni F. Chondroblastoma-like osteosarcoma. Orthopedics 1999; 22; 337-339.
62. Biscaglia R, Gasbarrini A, Bohling T, Bacchini P, Bertoni F, Picci P. Osteosarcoma of the bones of the foot - an easily misdiagnosed malignant tumor. Mayo Clin. Proc. 1998; 73; 842-847.
63. Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am. J. Clin. Pathol. 2006; 125; 555-581.
64. Bergmann F, Andrulis M, Hartwig W et al. Discovered on gastrointestinal stromal tumor 1 (DOG1) is expressed in pancreatic centroacinar cells and in solid-pseudopapillary neoplasms-novel evidence for a histogenetic relationship. Hum. Pathol. 2011; 42; 817-823.